Advertisement
U.S. Markets closed

ProPhase Labs, Inc. (PRPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.7500-0.0014 (-0.19%)
At close: 04:00PM EST
0.7700 +0.02 (+2.67%)
After hours: 04:19PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.7514
Open0.7310
Bid0.7060 x 100
Ask0.7801 x 100
Day's Range0.7050 - 0.7700
52 Week Range0.6600 - 7.4800
Volume132,407
Avg. Volume100,353
Market Cap17.905M
Beta (5Y Monthly)-0.09
PE Ratio (TTM)N/A
EPS (TTM)-1.4800
Earnings DateNov 13, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 24, 2022
1y Target Est18.50
  • Zacks

    ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates

    ProPhase Labs (PRPH) delivered earnings and revenue surprises of -12.90% and 11.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024

    Highlights Q4 2024 and Q1 2025 with multiple potential liquidity events, growth in multiple subsidiaries as well as potentially significant reduction in overhead and expenses Company to hold a virtual conference call Wednesday, November 13, 2024, at 11:00 AM ET GARDEN CITY, NY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its financial and operational results for th